Suppr超能文献

哪些抗磷脂抗体患者应该接受治疗以及如何治疗?

Which patients with antiphospholipid antibody should be treated and how?

作者信息

Lockshin M D

机构信息

National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

出版信息

Rheum Dis Clin North Am. 1993 Feb;19(1):235-47.

PMID:8356257
Abstract

The tests for antiphospholipid antibody are relatively crude but usable. Asymptomatic persons with incidentally discovered antiphospholipid antibody do not need treatment. Those with symptoms are best treated with anticoagulation, but data specifically supporting aspirin, heparin, or warfarin or combinations thereof remain to be generated. High-dose corticosteroid therapy has at best equivocal efficacy and much toxicity and should be used only for lupus activity and not for phenomena of the antiphospholipid antibody syndrome. The roles of low-dose corticosteroid therapy, immunosuppressive agents, and other treatments are unknown.

摘要

抗磷脂抗体检测相对粗略但可用。偶然发现抗磷脂抗体的无症状者无需治疗。有症状者最好采用抗凝治疗,但具体支持阿司匹林、肝素、华法林或其联合使用的数据仍有待生成。高剂量皮质类固醇疗法疗效充其量不明确且毒性很大,仅应用于狼疮活动期,而不适用于抗磷脂抗体综合征的症状。低剂量皮质类固醇疗法、免疫抑制剂及其他治疗方法的作用尚不清楚。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验